One in three individuals with major depressive disorder does not get relief from standard daily antidepressant medications. The up-and-coming psychedelic therapeutics like psilocybin or LSD do show ...

Researchers say people with ‘circadian depression’ might benefit from therapies that help adjust the body’s clock.

Helus Pharma, formerly known as Cybin (NASDAQ:HELP), outlined its late-stage development plans for HLP-003 in adjunctive major depressive disorder (MDD) and discussed its broader pipeline of ...

Please provide your email address to receive an email when new articles are posted on . Major depression is a common reason patients experience poor outcomes. Even after depression is diagnosed, it ...

A new study identifies a stable, brain-derived RNA molecule in the bloodstream that accurately predicts whether a patient ...

A new study that measured brain activity in 263 people with depression suggests the diagnosis we give everyone might be covering five different conditions.

Researchers found that 8.3% of US adults had at least one major depressive episode. In adolescents, the rate was 20.1%, with 29.2% of female adolescents reporting a major depressive episode. Major ...

Among youths who misused each drug class, those with depression were more likely to cite helping with feelings and emotions as their main reason for misusing opioid analgesics (10.2% vs 3.7%; P = .01) ...

Major depression fluctuates during and after pregnancy but has the highest prevalence two weeks after giving birth, a University of Queensland study has found. Researchers used data from 780 studies, ...

How common is major depression? At least 10% of people in the U.S. will experience major depressive disorder at some point in their lives. Two times as many women as men experience major depression.

Real-world data show fezolinetant is linked to improved vasomotor symptoms, depression, and anxiety as early as 4 weeks.